Intel Lobbies For Home-Based Medical Technology
This article was originally published in The Gray Sheet
Executive SummaryMany members of Congress working on health care reform do not appreciate the full potential of technology to make the U.S. health care system more cost-effective, according Eric Dishman, director of Health Innovation and Policy for Intel's Digital Health Group
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.